Charity News from Tuesday, Mar. 14, 2000Tailored Use of Platelet Inhibitors may Prevent Second Heart AttacksDuke University Medical Center | Researchers at Duke University Medical Center think they know why glycoprotein IIb/IIIa platelet inhibitor drugs, collectively known as "super aspirins," produce only modest benefit for patients with acute coronary syndromes. Heart Drug Cuts Death and Heart Attack Rate by 40 Percent in Angioplasty-Stent Procedure Duke University Medical Center | A drug designed to prevent blood clots from developing during a common heart procedure performed so well that the Duke University physicians who tested it predict it will alter medical practice. Gene Therapy Useful in Treating Major Complication of Cirrhosis of the Liver in Animal Studies Duke University Medical Center | Duke University Medical Center researchers, using a modified cold virus, have delivered a nitric oxide producing gene to key liver cells in rats, reversing the major complication of cirrhosis of the liver. Aspirin Wins Out Over Its Super Aspirin Challenger Duke University Medical Center | Good old aspirin stood firm against its would-be rival, sibrafiban, in a clot-prevention trial that may spell the end of the oral glycoprotein IIb/IIIa "super aspirin" challenge. Aggressive Treatment Recommended for In-Hospital Heart Attacks Duke University Medical Center | One out of three patients worldwide who suffer a second heart attack shortly after being hospitalized for a first heart attack are not receiving the best care available, according to a new analysis by Duke University Medical Center researchers.
|
|
